We are live on
!
Find out more
Commonwealth Equity Services Portfolio holdings
AUM
$79.5B
1-Year Est. Return
27.1%
This Fund
S&P 500
This Quarter
Est. Return
+15.68%
1 Year Est. Return
+27.1%
3 Year Est. Return
+78.53%
5 Year Est. Return
+87.9%
10 Year Est. Return
+281.22%
AUM
$79.5B
AUM Growth
+$7.93B
(+11%)
Cap. Flow
-$643M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
16.98%
Holding
4,611
New
312
Increased
1,846
Reduced
2,170
Closed
196
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$70M |
| 2 |
Putnam Focused Large Cap Value ETF
PVAL
|
+$65.3M |
| 3 |
Fidelity Fundamental Large Cap Growth ETF
FFLG
|
+$50M |
| 4 |
Eli Lilly
LLY
|
+$42.5M |
| 5 |
SPCX
SpaceX
SPCX
|
+$40.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$122M |
| 2 |
NVIDIA
NVDA
|
+$99.2M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.3M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$79.7M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$69.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.62% |
| 2 | Technology | 12.02% |
| 3 | Financials | 4.01% |
| 4 | Industrials | 3.47% |
| 5 | Consumer Discretionary | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
NeuroSense Therapeutics
NRSN
$19.3M
| $16.4K | ﹤0.01% |
22,775
| – | – |
|
4352
Hyperfine
HYPR
$86.2M
| $16.1K | ﹤0.01% |
11,910
-8,000
| -40% | -$11.6K |
|
4353
PharmaCyte Biotech
PMCB
$5.22M
| $15.6K | ﹤0.01% |
20,255
+9,942
| +96% | +$7.48K |
|
|
DEFT
4354
Defi Technologies
DEFT
$265M
| $15.1K | ﹤0.01% |
29,284
-1,000
| -3% | -$678 |
|
4355
BRC Inc
BRCC
$125M
| $14.9K | ﹤0.01% |
1,340
+107
| +9% | +$1.32K |
|
4356
Akebia Therapeutics
AKBA
$270M
| $14.4K | ﹤0.01% |
12,610
| – | – |
|
4357
Milestone Scientific
MLSS
$41.6M
| $14.4K | ﹤0.01% |
44,782
| – | – |
|
4358
GEE Group
JOB
$26.3M
| $13.9K | ﹤0.01% |
66,200
| – | – |
|
4359
Goldgroup Mining
GORO
$563M
| $12.9K | ﹤0.01% |
+10,205
| New | +$13.9K |
|
|
GLDG
4360
GoldMining Inc
GLDG
$232M
| $12.8K | ﹤0.01% |
14,135
| – | – |
|
|
CRDL
4361
Cardiol Therapeutics
CRDL
$257M
| $12.2K | ﹤0.01% |
11,495
+395
| +4% | +$500 |
|
4362
Hain Celestial
HAIN
$67.5M
| $11.9K | ﹤0.01% |
21,269
| – | – |
|
|
YARW
4363
Yarrow Bioscience
YARW
$80.7M
| $11.9K | ﹤0.01% |
366
| – | – |
|
|
FFAI
4364
Faraday Future Intelligent Electric
FFAI
$7.13M
| $11.6K | ﹤0.01% |
337
+100
| +42% | +$4.94K |
|
4365
Dyadic International
DYAI
$20.8M
| $11.3K | ﹤0.01% |
12,579
| – | – |
|
4366
cbdMD
YCBD
$5.33M
| $10.9K | ﹤0.01% |
16,255
| – | – |
|
4367
Humacyte
HUMA
$168M
| $10.4K | ﹤0.01% |
13,330
-2,869
| -18% | -$2.66K |
|
4368
Blink Charging
BLNK
$85.3M
| $9.87K | ﹤0.01% |
15,419
-1,574
| -9% | -$1.14K |
|
4369
Prairie Operating Co
PROP
$51.1M
| $9.76K | ﹤0.01% |
13,530
| – | – |
|
|
AIFC
4370
AI Financial Corp
AIFC
$78.4M
| $9.65K | ﹤0.01% |
16,500
+3,000
| +22% | +$2.51K |
|
4371
SunPower Inc
SPWR
$75.2M
| $9.62K | ﹤0.01% |
+14,000
| New | +$13.7K |
|
|
ORIO
4372
Orion Digital Corp
ORIO
$23.1M
| $9.38K | ﹤0.01% |
+11,032
| New | +$10.6K |
|
4373
IGC Pharma
IGC
$30.8M
| $9.07K | ﹤0.01% |
33,348
-500
| -1% | -$148 |
|
4374
Microvision
MVIS
$50.5M
| $8.87K | ﹤0.01% |
1,809
+1,014
| +128% | +$8.36K |
|
4375
BiomX
PHGE
$3.95M
| $8.14K | ﹤0.01% |
+23,414
| New | +$26.9K |
|
Similar funds
BC
Commonwealth Equity Services's Q2 2026 Portfolio in Review
As of Q2 2026, Commonwealth Equity Services held 4,611 positions worth $79.5B, up 11% from $71.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Commonwealth Equity Services's Q2 2026 filing shows 312 new, 1,846 increased, 2,170 reduced and 196 closed positions. Its largest new stake was SpaceX: 238,120 shares worth $40.7M. The largest sale was Apple, an estimated $122M.
By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, up from 66% a quarter earlier, followed by Technology and Financials.
- Commonwealth Equity Services's largest Q2 2026 buy was SpaceX: 238,120 shares worth $40.7M.
- Commonwealth Equity Services added most to Invesco NASDAQ 100 ETF in Q2 2026, an estimated $70M increase.
- Commonwealth Equity Services's biggest Q2 2026 reduction was Apple, cutting an estimated $122M.
- Commonwealth Equity Services fully exited Convergence Long/Short Equity ETF in Q2 2026, selling an estimated $7.88M.
- Commonwealth Equity Services's ten largest holdings make up 17% of its $79.5B portfolio in Q2 2026.
- Commonwealth Equity Services opened 312 new positions and closed 196 in Q2 2026.
- Commonwealth Equity Services's portfolio value rose 11% quarter-over-quarter to $79.5B.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.